Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03088033 · ClinicalTrials.gov registry record · NA
Reduce Lap-hf Trial II
A NA study of Heart Failure, sponsored by Corvia Medical.
- Active
- Registry status
- NA
- Development phase
- 608
- Enrollment target
- 20
- Study locations
NCT03088033 is a NA study of Heart Failure that is active but no longer recruiting, run by Corvia Medical. The registered enrollment target is 608 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (70% lower). The trial reports 20 study locations across 10 states.
The verdict
NCT03088033, a NA study of Heart Failure, is active but no longer recruiting, sponsored by Corvia Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 608 participants
- Enrollment target
- 20
- Study locations
Study Summary
Multicenter, Prospective, Randomized Controlled, Blinded Trial, with a Non-implant Control group; 1:1 randomization.
Conditions Studied
Interventions
- DEVICE IASD System II implant
- OTHER intra-cardiac echocardiography (ICE), or transesophageal echocardiography (TEE)
Study Locations (20)
Florida
- Holy Cross Hospital - Fort Lauderdale
- Sarasota Memorial Hospital - Sarasota
- Tallahassee Research Institute, Inc. - Tallahassee
- Cleveland Clinic Florida - Weston
California
- Scripps Clinic - La Jolla
- Kaiser Permanente San Diego - La Jolla
- Kaiser Permanente San Francisco Medical Center - San Francisco
Illinois
- Northwestern University - Chicago
- University of Chicago Medical Center - Chicago
- Evanston Northshore Healthcare - Evanston
Arizona
- Arizona Cardiovascular Research Center - Phoenix
- University of Arizona College of Medicine - Tucson
Louisiana
- Cardiovascular Institute of the South - Houma
- Ochsner Clinic Foundation - New Orleans
Massachusetts
- Tufts New England Medical Center - Boston
- Massachusetts General Hospital - Boston
Colorado
- South Denver Cardiology Associates - Littleton
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 608 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2026-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03088033
The ClinicalTrials.gov registry entry for NCT03088033 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 608 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (70% lower). The listed sponsor is Corvia Medical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which IASD System II implant is the first listed.
NCT03088033 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Florida, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT03088033 about?
NCT03088033 is a clinical study titled "Reduce Lap-hf Trial II". Multicenter, Prospective, Randomized Controlled, Blinded Trial, with a Non-implant Control group; 1:1 randomization.
What is the current status of trial NCT03088033?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 608 participants. The study started on 2017-06-01. Estimated completion is 2026-09.
What conditions does trial NCT03088033 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT03088033?
The interventions under investigation include: IASD System II implant (DEVICE), intra-cardiac echocardiography (ICE), or transesophageal echocardiography (TEE) (OTHER).
Who is sponsoring clinical trial NCT03088033?
This trial is sponsored by Corvia Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03088033 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Connecticut, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.